KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Shares Repurchased (2016 - 2025)

AbbVie (ABBV) has disclosed Shares Repurchased for 13 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Shares Repurchased fell 99.16% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $980.0 million through Dec 2025, down 42.62% year-over-year, with the annual reading at $980.0 million for FY2025, 42.62% down from the prior year.
  • Shares Repurchased for Q4 2025 was $3.0 million at AbbVie, down from $4.0 million in the prior quarter.
  • The five-year high for Shares Repurchased was $2.0 billion in Q1 2023, with the low at $3.0 million in Q4 2023.
  • Average Shares Repurchased over 5 years is $354.0 million, with a median of $10.0 million recorded in 2021.
  • The sharpest move saw Shares Repurchased soared 11833.33% in 2024, then tumbled 99.16% in 2025.
  • Over 5 years, Shares Repurchased stood at $131.0 million in 2021, then crashed by 96.95% to $4.0 million in 2022, then decreased by 25.0% to $3.0 million in 2023, then skyrocketed by 11833.33% to $358.0 million in 2024, then crashed by 99.16% to $3.0 million in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $3.0 million, $4.0 million, and $12.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.